menu
    • menu

    Company profile for Innovent Biologics

    NEW Drugs in Dev: 86
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is to create a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs that are affordable to ordinary people. we have developed our fully-integrated platform which includes R&D, CMC (Chemistry, Manufacturing, and Control), clinical trial and commercialization capabilities. These capabilities have enabled us to build a robust pipeline of innovative and commercially prom...
    Our mission is to create a world-class China-based biopharmaceutical company that develops and commercializes high quality drugs that are affordable to ordinary people. we have developed our fully-integrated platform which includes R&D, CMC (Chemistry, Manufacturing, and Control), clinical trial and commercialization capabilities. These capabilities have enabled us to build a robust pipeline of innovative and commercially promising monoclonal antibodies and other biologics in the fields of oncology, ophthalmology, autoimmune, and cardiovascular diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Innovent BiologicsChina Flag
    Country
    Country
    China
    Address
    Address
    168 Dongping Street, Suzhou Industrial Park,Jiangsu
    Telephone
    Telephone
    (86)0512-69566088
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://cn.innoventbio.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/innovent-biologics-inc-/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    IMCAS World Congress

    IMCAS World Congress

    Not Confirmed

    envelop Contact Supplier

    IMCAS World Congress

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Takeda Leader Says AI Gave Early-Stage Asset A 'Phoenix' Rebirth
    Takeda Leader Says AI Gave Early-Stage Asset A 'Phoenix' Rebirth

    13 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/jpm26-takedas-rd-head-talks-slow-monday-biggest-threat-us-innovation-phoenix-rising-ashes

    FIERCE BIOTECH
    13 Jan 2026
    Share Share
    NMPA OKs Innovent's TABOSUN: China's 1st Domestic Anti-CTLA-4 mAb
    NMPA OKs Innovent's TABOSUN: China's 1st Domestic Anti-CTLA-4 mAb

    25 Dec 2025

    // PR NEWSWIRE BIO

    https://www.prnewswire.com/news-releases/chinas-first-domestic-anti-ctla-4-monoclonal-antibody-innovents-tabosun-ipilimumab-n01-injection-received-nmpa-approval-302649444.html

    PR NEWSWIRE BIO
    25 Dec 2025
    Share Share
    Two Phase 3 Mazdutide Results Reported for T2D in Chinese Adults
    Two Phase 3 Mazdutide Results Reported for T2D in Chinese Adults

    17 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nature--two-phase-3-clinical-results-of-mazdutide-glp-1gcg-dual-receptor-agonist-in-chinese-adults-with-type-2-diabetes-have-been-back-to-back-published-in-nature-302644606.html

    PR NEWSWIRE
    17 Dec 2025
    Share Share
    Mazdutide Cuts Weight in Chinese Phase 1b Obesity Trial
    Mazdutide Cuts Weight in Chinese Phase 1b Obesity Trial

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/mazdutide-demonstrates-significant-weight-loss-and-metabolic-benefits-in-phase-1b-clinical-trial-in-chinese-adolescents-with-obesity-302639274.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share
    Innovent Doses First Patient in IBI3011 Phase 1 Trial
    Innovent Doses First Patient in IBI3011 Phase 1 Trial

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-announces-first-participant-dosed-in-a-phase-1-clinical-trial-of-ibi3011-a-recombinant-anti-human-interleukin-1-receptor-accessory-protein-monoclonal-antibody-302637265.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    Innovent Reports PECONDLE Phase 3 (CLEAR-2) Success In Psoriasis
    Innovent Reports PECONDLE Phase 3 (CLEAR-2) Success In Psoriasis

    09 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/innovent-announces-pecondle-picankibart-injection-phase-3-study-clear-2-meets-endpoints-delivering-superior-long-term-management-solution-for-moderate-to-severe-psoriasis-302635212.html

    PR NEWSWIRE
    09 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search